Liling Yue

726 total citations
30 papers, 593 citations indexed

About

Liling Yue is a scholar working on Molecular Biology, Cancer Research and Toxicology. According to data from OpenAlex, Liling Yue has authored 30 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Toxicology. Recurrent topics in Liling Yue's work include Bioactive Compounds and Antitumor Agents (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Bioactive Natural Diterpenoids Research (3 papers). Liling Yue is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Bioactive Natural Diterpenoids Research (3 papers). Liling Yue collaborates with scholars based in China. Liling Yue's co-authors include Jicheng Liu, Hongxia Cui, Jicheng Liu, Likun Liu, Yongxu Sun, Ying Yang, Defu Cai, Guihua Xing, Chunjing Zhang and Xiaohui Du and has published in prestigious journals such as Carbohydrate Polymers, Molecules and Sensors and Actuators B Chemical.

In The Last Decade

Liling Yue

28 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liling Yue China 17 323 97 70 70 69 30 593
Bushra Ijaz Pakistan 15 276 0.9× 78 0.8× 56 0.8× 63 0.9× 59 0.9× 48 908
Mohammad Jalili‐Nik Iran 18 338 1.0× 107 1.1× 69 1.0× 103 1.5× 67 1.0× 52 862
Sonam Mittal India 14 406 1.3× 111 1.1× 59 0.8× 52 0.7× 45 0.7× 28 701
Khushbukhat Khan Pakistan 16 415 1.3× 125 1.3× 34 0.5× 68 1.0× 45 0.7× 65 803
Firdous Ahmad Bhat India 13 398 1.2× 136 1.4× 100 1.4× 54 0.8× 110 1.6× 31 861
T. R. Santhosh Kumar India 19 484 1.5× 99 1.0× 75 1.1× 92 1.3× 101 1.5× 40 992
Gang Fang China 14 233 0.7× 50 0.5× 59 0.8× 62 0.9× 57 0.8× 41 697
Balakrishnan Solaimuthu India 11 349 1.1× 120 1.2× 99 1.4× 56 0.8× 109 1.6× 22 706
Minghua Liu China 14 255 0.8× 116 1.2× 60 0.9× 42 0.6× 61 0.9× 39 568

Countries citing papers authored by Liling Yue

Since Specialization
Citations

This map shows the geographic impact of Liling Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liling Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liling Yue more than expected).

Fields of papers citing papers by Liling Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liling Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liling Yue. The network helps show where Liling Yue may publish in the future.

Co-authorship network of co-authors of Liling Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Liling Yue. A scholar is included among the top collaborators of Liling Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liling Yue. Liling Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wei, et al.. (2025). Engineered celastrol liposomes with glycyrrhizic acid augment synergistic antitumor efficacy in breast cancer. Frontiers in Oncology. 15. 1602585–1602585.
2.
Sun, Chenxi, Yongrui Zhang, Xiuli Gao, et al.. (2025). Curcumin encapsulation in self-assembled nanoparticles based on amphiphilic stearic acid–grafted inulin: Preparation, characterization, and functional evaluation. International Journal of Biological Macromolecules. 301. 140302–140302.
3.
Zhang, Wei, Jiping Li, Liling Yue, & Chenfeng Ji. (2024). Targeted Delivery of Celastrol by GA-Modified Liposomal Calcium Carbonate Nanoparticles to Enhance Antitumor Efficacy Against Breast Cancer. Pharmaceutics. 16(11). 1382–1382. 4 indexed citations
4.
Li, Jiping, et al.. (2024). Preparation, in vitro anti-tumour activity and in vivo pharmacokinetics of RGD-decorated liposomes loaded with shikonin. Pharmaceutical Development and Technology. 29(3). 153–163. 1 indexed citations
5.
6.
Zhang, Qi, Dong Li, Shuang Guan, et al.. (2022). Tumor-targeted delivery of honokiol via polysialic acid modified zein nanoparticles prevents breast cancer progression and metastasis. International Journal of Biological Macromolecules. 203. 280–291. 28 indexed citations
8.
Liu, Likun, Shuang Fu, Liling Yue, et al.. (2020). A Gas Sensor With Fe2O3 Nanospheres Based on Trimethylamine Detection for the Rapid Assessment of Spoilage Degree in Fish. Frontiers in Bioengineering and Biotechnology. 8. 567584–567584. 42 indexed citations
9.
Liu, Likun, Haitao Yu, Hongxia Cui, et al.. (2018). Chloroquine inhibits cell growth in human A549 lung cancer cells by blocking autophagy and inducing mitochondrial‑mediated apoptosis. Oncology Reports. 39(6). 2807–2816. 24 indexed citations
10.
Yue, Liling, et al.. (2016). TOX3 protein expression is correlated with pathological characteristics in breast cancer. Oncology Letters. 11(3). 1762–1768. 13 indexed citations
12.
13.
Sun, Chao, Hongxia Cui, Hongyan Yang, et al.. (2015). Anti-metastatic effect of jolkinolide B and the mechanism of activity in breast cancer MDA-MB-231 cells. Oncology Letters. 10(2). 1117–1122. 25 indexed citations
14.
Cui, Hongxia, et al.. (2014). Effects of Overexpression of Exogenous FUT7 on Adhesion and Migration of Breast Cancer Cell. 41(3). 252–255. 1 indexed citations
15.
Cui, Hongxia, Jiaxin Yuan, Xiaohui Du, et al.. (2014). Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling. Oncology Reports. 33(3). 1284–1290. 35 indexed citations
16.
Bi, Hong‐Yan, et al.. (2013). Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells. Cell Death and Disease. 4(9). e814–e814. 54 indexed citations
17.
Pan, Weisan, Cuiyan Han, Liling Yue, et al.. (2013). A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro. International Journal of Nanomedicine. 8. 1541–1541. 30 indexed citations
18.
Chen, Jie, Jincai Hou, Jingjie Zhang, et al.. (2012). Atorvastatin synergizes with IFN-γ in treating human non-small cell lung carcinomas via potent inhibition of RhoA activity. European Journal of Pharmacology. 682(1-3). 161–170. 12 indexed citations
19.
Sun, Yongxu, Jianhua Liu, Liling Yue, et al.. (2011). One proteoglycan from the fruiting bodies of Chroogomphis rutilus (Schaeff.: Fr.) O.K. Miller: purification and structural features. Carbohydrate Polymers. 86(3). 1381–1384. 8 indexed citations
20.
Liu, Jicheng, Yongxu Sun, Haitao Yu, et al.. (2011). Purification and identification of one glucan from golden oyster mushroom (Pleurotus citrinopileatus (Fr.) Singer). Carbohydrate Polymers. 87(1). 348–352. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026